Increased injection pain with darbepoetin-α compared to epoetin-β in paediatric dialysis patients

Nephrology Dialysis Transplantation

Volumn 21, Issue 12, 2006, Pages 3520-3524

  Schmitt, Claus Peter ^a   Nau, Barbara ^a   Brummer, Christiane ^a   Rosenkranz, Joachim ^a   Schaefer, Franz ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Anaemia; Darbepoetin ; Epoetin ; Paediatric dialysis; Pain perception; Subcutaneous injection

Indexed keywords

NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RECOMBINANT ERYTHROPOIETIN;

ADOLESCENT; ADULT; ANEMIA; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INJECTION SITE PAIN; KIDNEY FAILURE; MALE; NOCICEPTION; PAIN ASSESSMENT; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; VISUAL ANALOG SCALE;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; ERYTHROPOIETIN; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; MALE; PAIN; PROSPECTIVE STUDIES; RENAL DIALYSIS; SEVERITY OF ILLNESS INDEX;

EID: 33751417138     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl479     Document Type: Article

References (18)

1. Jurkovitz CT, Abramson JL, Vaccarino LV, Weintraub WS, McClellan WM. Association of high serum creatinine and anemia increases the risk of coronary events: Results from the prospective community-based atherosclerosis risk in communities (ARIC) study. J Am Soc Nephrol 2003; 14: 2919-2925
2. Pisoni RL, Bragg-Gresham JL, Young EW et al. Anemia management and outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2004; 44: 94-111
3. Macdougall IC, Gray SJ, Elston O et al. Pharmacokinetics of novel erythropoiesis stimulating protein compared with epoetin alfa in dialysis patients. J Am Soc Nephrol 1999; 10: 2392-2395
4. Lerner G, Kale AS, Warady BA et al. Pharmacokinetics of darbepoetin alfa in pediatric patients with chronic kidney disease. Pediatr Nephrol 2002; 17: 933-937
5. Brunkhorst R, Bommer J, Braun J et al. Darbepoetin alfa effectively maintains haemoglobin concentrations at extended dose intervals relative to intravenous or subcutaneous recombinant human erythropoietin in dialysis patients. Nephrol Dial Transplant 2004; 19: 1224-1230
6. Ling B, Walczyk M, Agarwal A, Carroll W, Liu W, Brenner R. Darbepoetin alfa administered once monthly maintains hemoglobin concentrations in patients with chronic kidney disease. Clin Nephrol 2005; 63: 327-334
7. Geary DF, Keating LE, Vigneux A, Stephens D, Hebert D, Harvey EA. Darbepoetin alfa (Aranesp) in children with chronic renal failure. Kidney Int 2005; 68: 1759-1765
8. Cummings EA, Reid GJ, Finley GA, McGrath PJ, Ritchie JA. Prevalence and source of pain in pediatric inpatients. Pain 1996; 68: 25-31
9. Morris KP, Hughes C, Hardy SP, Matthews JN, Coulthard MG. Pain after subcutaneous injection of recombinant human erythropoietin: Does Emla cream help? Nephrol Dial Transplant 1994; 9: 1299-1301
10. Kleiber C, Sorenson M, Whiteside K, Gronstal BA, Tannous R. Topical anesthetics for intravenous insertion in children: A randomized equivalency study. Pediatrics 2002; 110: 758-761
11. Dahlquist LM, Gil KM, Armstrong FD, DeLawyer DD, Greene P, Wuori D. Preparing children for medical examinations: The importance of previous medical experience. Health Psychol 1986; 5: 249-259
12. Frank NC, Blount RL, Smith AJ, Manimala MR, Martin JK. Parent and staff behavior, previous child medical experience, and maternal anxiety as they relate to child procedural distress and coping. J Pediatr Psychol 1995; 20: 277-289
13. Granolleras C, Leskopf W, Shaldon S, Fourcade J. Experience of pain after subcutaneous administration of different preparations of recombinant human erythropoietin: A randomized, double-blind crossover study. Clin Nephrol 1991; 36: 294-298
14. Veys N, Dhondt A, Lameire N. Pain at the injection site of subcutaneously administered erythropoietin: Phosphate-buffered epoetin alpha compared to citrate-buffered epoetin alpha and epoetin beta. Clin Nephrol 1998; 49: 41-44
15. Singer AJ, Gulla J, Thode HC,Jr. Parents and practitioners are poor judges of young children's pain severity. Acad Emerg Med 2002; 9: 609-612
16. Wiesenfeld-Hallin Z. Sex differences in pain perception. Gend Med 2005; 2: 137-145
17. Dionne RA, Bartoshuk L, Mogil J, Witter J. Individual responder analyses for pain: Does one pain scale fit all? Trends Pharmacol Sci 2005; 26: 125-130
18. Grzeszczak W, Sulowicz W, Rutkowski B et al. The efficacy and safety of once-weekly and once-fortnightly subcutaneous epoetin beta in peritoneal dialysis patients with chronic renal anaemia. Nephrol Dial Transplant 2005; 20: 936-944